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Estimation and projection of the national profile of cancer
mortality in China: 1991–2005
L Yang*,1,2, DM Parkin1, LD Li2, YD Chen3 and F Bray1
1International Agency for Research on Cancer, 150, cours Albert Thomas, 69372 Lyon, Cedex 08, France; 2National Off ice for Cancer Prevention and
Control, 17 South Lane, Panjiayuan, Chaoyang District, Beijing 10021, PR China; 3Center of Health Information and Statistics of Ministry of Health/Public
Health School, Peking University, 38 Xueyuan Road, Beijing 100083, PR China
There are no national-level data on cancer mortality in China since two surveys in 1973–1975 and 1990–1992 (a 10% sample), but
ongoing surveillance systems, based on nonrandom selected populations, give an indication as to the trends for major cancers. Based
on a log-linear regression model with Poisson errors, the annual rates of change for 10 cancers and all other cancers combined, by
age, sex and urban/rural residence were estimated from the data of the surveillance system of the Center for Health Information and
Statistics, covering about 10% of the national population. These rates of change were applied to the survey data of 1990–1992 to
estimate national mortality in the year 2000, and to make projections for 2005. Mortality rates for all cancers combined, adjusted for
age, are predicted to change little between 1991 and 2005 (0.8% in men and þ 2.5% in women), but population growth and ageing
will result in an increasing number of deaths, from 1.2 to 1.8 million. The largest predicted increases are for the numbers of female
breast (þ 155.4%) and lung cancers (þ 112.1% in men, þ 153.5% in women). For these two sites, mortality rates will almost double.
Cancer will make an increasing contribution to the burden of diseases in China in the 21st century. The marked increases in risk of
cancers of the lung, female breast and large bowel indicate priorities for prevention and control. The increasing trends in young age
groups for cancers of the cervix, lung and female breast suggest that their predicted increases may be underestimated, and that more
attention should be paid to strategies for their prevention and control.
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Comparison of two representative surveys of mortality in China (in
1973– 1975 and 1990– 1992) (NOCPC, 1979; Li et al, 1996) shows
that overall cancer mortality has increased, and that the trends
differ depending on the type of cancer and urban/rural area of
residence (Li et al, 1996). An accurate knowledge of cancer
patterns and their likely evolution in the future are essential in the
planning of national cancer control programmes (WHO, 2002).
However, the absence of national statistics on mortality or
incidence of cancer in China (Yang et al, 2003a) means that
estimation procedures, using available ongoing surveillance
systems, are required.
The most comprehensive data on mortality in China are those
from the continuing surveillance system, involving 36 cities and 85
counties, that was conducted by the Center for Health Information
and Statistics (CHIS). This system covers a population of about
100–120 millions (about 10% of the Chinese population), and is
used by WHO to report mortality rates for the urban and rural
populations of China (Cancer Mortality Database, 2003; Yang et al,
2003a).The surveillance areas do not represent a random sample of
the Chinese population, but are located in the more easily accessible
cities and counties, on the eastern seaboard, where vital statistics
systems are relatively well developed (Yang et al, 2003a). As a result,
the mortality rates are not the same as those in the representative
national survey, although after appropriate weighting by age, sex
and urban–rural status show a close approximation for many sites
(Yang et al, 2004: in press). The trends in mortality within such
strata are probably representative of those at the national level. We
use observed trends since 1991, and the data from the national
mortality survey of 1990–1992, to estimate cancer mortality rates in
China in 2000, and to prepare projections to the year 2005. These
rates, combined with knowledge of expected changes in the size and
age structure of the population, allow estimation of current and
future numbers of cancer deaths at the national level.
MATERIAL AND METHODS
Material
The following sources of data were used:
(1) Population details, by sex, age group and urban/rural
residence from the 1990 and 2000 censuses (Population
Census Office, 1993, 2002).
(2) The projected population in 2005, by age and sex, from the
United Nations Population Division (UN Population Division,
2003);
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(3) The estimated urban : rural ratios of the total population in
1995, 1998, 1999 and 2000 (from census data) (Population
Census Office, 2002; UN Statistics Division, 2002a); and
(4) Cancer mortality rates, by cause (10 sites), sex, age group and
urban/rural residence from the second National Mortality
Survey in 1990–1992 (Li et al, 1996; Zhou et al, 1997), and for
each year (1991–1999) from the population covered by the
cancer reporting system of CHIS (Cancer Mortality Database,
2003);
Population estimation and projection
The annual change in the proportion of the total population
classified as rural was calculated from the UN population estimates
from 1995 to 1999 (UN Statistics Division, 2002a) and 2000 census
data (Population Census Office, 2002). The exponential of this
change was applied to estimate the proportion of the total
population in 2005 having rural residence (and, by subtraction,
urban). This proportion (all ages) was used to obtain the
proportion in individual age groups, by multiplying the ratio of
% rural in the age group concerned with the % rural of all ages in
2000. These proportions were used to calculate the population
numbers by age, sex and urban and rural residence, from the UN
population projections (totals by age and sex) for 2005.
Estimates and projections of cancer mortality rates and
numbers of deaths
Mortality rates for each year (1991 –1999) for 10 specific cancer
sites, oesophagus, stomach, lung, liver, colon-rectum, female
breast, cervix uteri, nasopharynx, leukaemia and bladder, are
available in the CHIS data set (Cancer Mortality Database, 2003).
The estimated annual percent changes (EAPCs) in the rate for
these cancers, as well as all other cancers combined, for this 9-year
period were calculated by area (rural/urban), sex and age group
(0–4, 5– 14, 15–44, 45– 54, 55–64, 65–74, 75þ years), based on a
Poisson regression model. These rates of change were applied to
the mortality rates observed in the national mortality survey in
1990– 1992 to estimate the age-specific mortality rate at the
national level for the corresponding cancers from 1991 to 2005.
The model used was:
log E½Mit ¼ ai þ bit ð1Þ
where E½Mit  is the expected mortality rate of the cancer in age
group i and year t, ai is the baseline age-specific mortality rate
(when t¼ 0 e.g. 1991) and bi is the observed EAPC in the CHIS
data for the age group i (Hakulinen and Dyba, 1994).
With the exception of leukaemia, we assumed that mortality
remained constant in the youngest age group (less than 15 years
old), because of the uncertainty of the calculated EAPCs, which
were based on small numbers of deaths in this age group. The
expected numbers of deaths for each cancer, by age group, sex and
urban/rural residence were then calculated using the population
estimates for 1991–2005, estimated as described above. The
numbers were then summed for urban– rural categories, and
age-specific rates calculated for the whole population. Age-
standardised rates (ASRs) were calculated for years 1991, 2000
and 2005 using the weights of the world standard population. The
numbers of deaths and mortality rates for all cancers combined
were calculated by summing the estimates for the 11 categories (10
specific cancer sites, plus ‘other cancers’).
The changes in the numbers of deaths between 1991 and 2000 or
2005 are due to changes both in the risk of death from cancer and
in the size and structure of the population. We calculated the
component due to risk as the difference between the estimated
future deaths, and the number that would have occurred if the
mortality rates had remained the same as in 1991. The change due
to population size and ageing is obtained as the difference between
this latter figure, and the original number of deaths (in 1991)
(Engeland et al, 1993).
Sensitivity analysis
Other models have been suggested for making predictions of
future rates of disease, assuming Poisson-distributed counts in
strata defined by age and sex. In addition to the model employed
in this paper, Hakulinen and Dyba (1994) propose two other
models:
log E½Mit  ¼ ai þ bt ð2Þ
E½Mit ¼ ai þ bit ð3Þ
Model (2) assumes the same proportional log-linear changes over
time within age groups, while model (3) allows different linear
changes on an arithmetic scale among different age groups. The
log-linear model is usually chosen for cancers with decreasing or
stable trends, as it avoids prediction of negative rates, whereas
model (3) is useful for modelling increasing trends, as it avoids an
overestimation of the prediction often produced in models (1) and
(2). Dyba et al (1997) also proposed a simple nonlinear model:
EMit ¼ aið1 þ btÞ ð4Þ
This model assumes proportional effects for different age groups,
but with the constraint that the absolute change in age-specific
mortality is proportional to the corresponding baseline rates (ai),
and so that the shape of the age-incidence curve remains
unchanged.
To validate our choice of prediction model, each of the four
models was fitted to compare observed and expected numbers of
deaths, age-specific and age-standardised rates of cancers of the
lung (in rural females), breast (in rural females), oesophagus (in
urban females) and cervix cancer (in urban females) in 1999. Since
the small numbers of observations may produce unrealistic
increasing or decreasing trends for particular age groups, the
younger age groups (age 0–44) were combined.
RESULTS
Estimated and projected population data
Based on the latest population census, the total population of
China was 1.24 billion (0.64 male and 0.60 female subjects) in 2000
and is projected to be 1.32 billion (0.68 male and 0.64 female
subjects) in 2005 (Population Census Office, 2002; UN Population
Division, 2003). Figure 1 shows the population pyramids for 1990,
2000 (from census data) and 2005 by sex, age and area. The
proportion of the population in urban areas is increasing in each
age group, while that of people aged over 60 years also increased,
from 8.6% in 1990 to 10.5% in 2000, and 10.8% in 2005.
Recent trends in cancer mortality rates, and estimated and
projected numbers of deaths
The EAPCs of the mortality rates in the CHIS data set, by cancer
site, age group, area and sex, are shown in Table 1. The estimated
and projected national age-specific and age-standardised mortality
rates in 1991, 2000 and 2005 (prepared by combining the data for
rural and urban areas) are shown in Table 2, by site and sex. The
numbers of deaths in 1991, 2000 and 2005, the percentage changes
over time and the contributions due to changes in rates and
changes in population (size and age structure) by site and sex are
shown in Table 3.
The figures in appendix A show the observed trends in age-
standardised mortality rates for 10 cancers, and for the other
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cancers combined, by site, area and sex, based on the CHIS
surveillance results in 1991–1999 (symbolised as ‘Rural-O’ or
‘Urban-O’). The age-standardised mortality rates in 1991, based on
the national mortality survey in 1990–1992, are also shown (the
first point of the lines labelled as ‘Rural-E’ or ‘Urban-E’), together
with the expected evolution of this rate from 1992 to 2005 (the
remaining points on the lines), based on the EAPCs calculated
from the CHIS data. The estimated age-standardised mortality
rates for cancers of the oesophagus, stomach (in rural popula-
tions), lung (in rural female subjects) and cervix (in urban female
subjects) are somewhat higher than those observed in the CHIS
populations, while they are lower for cancers of the lung (in urban
females), colon-rectum (except in rural males), breast (in urban
females), bladder (in urban males) and other sites combined (in
urban populations).
During the study period, there were large increases in age-
standardised mortality rates of cancers of lung and breast, and to a
lesser extent, of liver, among all populations and among almost all
age groups (Table 2 and Appendix A). The dramatic increases in
the rates in populations younger than age 55 years if correct imply
that there will be further increases in risk from these cancers in
future. The increasing trends are much steeper among rural
populations, so that mortality rates from cancers of the lung and
breast are projected to reach the same levels as those in urban
areas by 2005, although they were considerably lower in rural
populations in 1991 (Appendix A). Along with population growth
and ageing, the escalation in mortality rates means that the
component of change in deaths due to risk is large; in female
subjects, it is responsible for a 50.5% increase in lung cancer
deaths, and a 54.8% increase in breast cancer by 2000, a change
that exceeds the contribution due to population growth and ageing
(Table 3).
The numbers of deaths for all cancers combined were calculated
by summing the predicted numbers of deaths for the individual
cancers plus ‘all other sites’. The ASRs in men are almost double
those in women. Compared with 1991, the ASRs have declined a
little in males (0.8%, from 162.4 per 105 to 161.1 per 105), but
increased slightly in female subjects (þ 2.5%, from 86.6 per 105 to
88.8 per 105) in 2005 (Table 2). The absolute numbers of deaths
from all cancers are predicted to increase from 1.2 million in 1991
(752 000 in male, 422 000 in female subjects) to 1.5 million in 2000
(993 000 in male, 550 000 in female subjects), and 1.8 million
in 2005 (1.1 million in male and 649 000 in female subjects)
(Table 3).
Figure 2 summarises the predicted numbers of deaths in 2000
and 2005, relative to 1991, by site and sex. Between 1991 and 2005,
Figure 1 Population pyramids for the years 1990, 2000, 2005 by area, sex and age group in China.
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Table 1 Estimated annual percent changes (EAPCs) in mortality rates of cancer by site, age, area and sex
Cancer EAPC (age group) (years) rural-male rural-female urban-male urban-female
Stomach 15–44 0.1 0.9 0.7 0.0
45–54 0.6 1.1 0.4 0.5
55–64 2.7 2.6 4.2 2.8
65–74 2.5 1.9 2.8 2.9
75+ 2.0 2.6 1.6 2.2
Oesophagus 15–44 2.8 5.5 5.1 0.1
45–54 2.0 4.1 2.3 4.3
55–64 3.8 3.9 4.0 4.3
65–74 1.5 3.3 3.4 3.9
75+ 1.7 1.7 1.9 2.4
Liver 15–44 0.5 2.6 2.0 2.1
45–54 1.7 2.4 1.2 0.2
55–64 0.3 0.7 2.2 0.4
65–74 1.8 1.0 0.3 0.6
75+ 2.0 0.8 0.3 1.1
Lung 15–44 4.4 2.4 4.1 3.0
45–54 4.6 6.7 1.8 0.0
55–64 0.5 4.1 2.3 0.5
65–74 3.9 4.7 0.9 1.3
75+ 4.8 5.3 2.6 3.6
Colon-rectal 15–44 1.5 1.5 0.7 0.9
45–54 0.7 0.5 3.6 2.0
55–64 0.3 0.5 0.5 0.9
65–74 2.1 0.5 2.2 1.6
75+ 1.1 2.2 1.5 1.3
Cervix 15–44 — 2.8 — 7.3
45–54 — 2.7 — 4.2
55–64 — 3.1 — 7.7
65–74 — 5.8 — 9.4
75+ — 6.5 — 7.6
Breast (female) 15–44 — 5.0 — 3.3
45–54 — 7.3 — 2.8
55–64 — 5.1 — 1.9
65–74 — 4.0 — 0.1
75+ — 0.0 — 1.0
Leukaemia 0–4 7.9 8.3 0.5 4.1
5–14 2.6 2.0 0.9 0.1
15–44 1.7 1.9 0.1 1.4
45–54 0.4 0.7 2.7 1.9
55–64 0.9 2.3 1.2 0.9
65–74 3.7 2.1 1.3 0.0
75+ 6.1 1.7 2.9 0.8
Nasopharynx 15–44 0.3 1.0 2.9 3.4
45–54 1.0 3.4 0.6 3.9
55–64 1.1 2.6 4.8 2.4
65–74 1.4 1.7 2.2 2.2
75+ 1.0 2.1 0.5 0.0
Bladder 15–44 2.4 8.7 4.1 7.6
45–54 1.8 3.5 3.5 4.0
55–64 1.0 3.3 1.9 1.4
65–74 0.3 3.4 0.9 3.3
75+ 1.2 2.9 0.1 0.0
Other Sites 15–44 0.5 0.6 0.7 1.7
45–54 1.3 1.7 2.1 0.9
55–64 0.1 0.6 1.9 0.7
65–74 1.8 0.3 0.2 1.9
75+ 1.1 0.3 1.9 2.3
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the largest increase is for female breast cancer (from 19 000 deaths
in 1991 to 48 000 in 2005, an increase of þ 155.4%), followed by
lung cancer (þ 112.1% in men, þ 153.5% in women) and liver
cancer (þ 58.4% in men, þ 72.2% in women).
The results of the sensitivity analysis, comparing the above
results, with the three other prediction models are shown in
Table 4, as the observed and estimated numbers of deaths (with
95% confidence intervals), and observed and estimated mortality
rates (with 95% confidence intervals) in 1999. The mortality rates
estimated by the selected model (1) are much closer to the
observed values, with the narrowest confidence intervals, both for
numbers of deaths and for the ASRs.
Table 2 Age-specific and age-standardised cancer mortality rates (per 100 000) for year 1991, 2000 and 2005, by site and sex
Year 1991 Year 2000 Year 2005
Age groups (years) Age groups (years) Age groups (years)
Cancer sex 15–4445–5455–6465–74 75+ WASR9115–4445–5455–6465–74 75+ WASR0015–4445–5455–6465–74 75+ WASR05
All sites Male 31.2 223.2 562.3 1042.7 1282.4 162.4 32.9 243.0 477.0 1048.9 1353.9 160.2 34.5 256.6 430.4 1066.4 1433.8 161.1
All sites Female 20.0 126.2 283.3 531.0 678.4 86.6 21.3 141.4 263.0 515.8 673.9 86.3 22.7 154.0 257.8 522.4 701.0 88.8
Stomach Male 4.0 48.7 145.8 293.0 344.6 40.3 3.9 45.5 109.4 229.4 289.6 32.7 3.9 43.3 89.4 198.3 261.9 28.8
Stomach Female 2.7 23.1 60.7 129.2 167.3 18.4 2.6 20.5 46.6 104.6 133.3 15.0 2.6 19.0 40.1 91.3 116.3 13.3
Oesophagus Male 2.1 31.4 96.5 203.5 248.4 27.2 1.7 27.0 66.9 167.8 210.0 21.6 1.7 25.0 52.0 147.8 188.5 18.8
Oesophagus Female 1.1 16.6 47.7 97.0 118.6 13.4 0.7 11.0 32.1 69.1 99.1 9.5 0.5 8.5 25.6 55.7 86.6 7.7
Liver Male 11.5 70.3 117.0 158.9 164.1 33.3 12.3 79.5 108.3 175.2 187.8 35.3 13.0 84.3 101.2 183.0 200.9 36.2
Liver Female 3.2 21.2 41.8 68.6 79.0 12.1 3.8 24.5 43.6 73.8 85.8 13.3 4.2 26.2 44.5 76.4 89.4 13.9
Lung Male 3.2 33.8 113.9 214.1 243.1 29.8 4.7 46.8 108.5 277.7 347.0 36.7 5.8 55.7 106.5 321.8 430.2 41.8
Lung Female 1.8 16.6 42.1 78.4 93.1 11.8 2.3 24.8 52.1 107.7 142.4 16.1 2.6 30.9 58.6 128.9 183.4 19.3
Colorectal Male 1.5 7.6 20.6 46.2 79.8 7.1 1.6 9.0 19.9 56.3 90.3 7.9 1.7 10.2 19.7 63.1 98.6 8.6
Colorectal Female 1.3 6.6 14.5 32.8 55.3 5.2 1.2 7.1 13.9 34.8 52.8 5.2 1.2 7.7 13.6 37.3 55.3 5.4
Cervix Female 0.9 7.8 13.9 26.1 28.5 4.2 1.2 10.0 9.4 14.0 15.4 3.4 1.4 11.3 7.5 9.7 10.9 3.2
Breast (female)Female 1.6 9.2 12.5 14.4 20.8 3.8 2.4 15.2 17.9 18.3 20.2 5.5 3.0 20.1 21.8 20.8 20.5 6.7
Leukaemia Male 3.4 4.5 6.5 8.8 8.9 4.1 3.0 5.0 6.7 11.5 13.8 4.2 2.9 5.5 6.7 13.3 17.8 4.4
Leukaemia Female 2.9 4.0 5.4 6.3 5.4 3.4 2.5 4.1 4.6 5.8 6.1 3.0 2.3 4.2 4.3 5.7 6.7 2.8
Nasopharynx Male 1.0 6.2 9.6 11.1 11.8 2.7 0.9 5.7 7.8 11.4 11.3 2.4 0.8 5.5 6.8 11.4 11.2 2.3
Nasopharynx Female 0.5 2.4 4.0 5.1 6.5 1.2 0.4 2.7 3.2 5.4 5.7 1.1 0.4 2.8 2.8 5.4 5.4 1.1
Bladder Male 0.1 1.1 4.3 13.9 35.7 1.9 0.1 1.3 3.9 14.0 34.4 1.9 0.1 1.5 3.6 14.1 35.1 1.9
Bladder Female 0.1 0.5 1.3 4.3 8.4 0.6 0.1 0.7 1.5 3.3 7.5 0.6 0.1 0.8 1.7 2.9 7.6 0.6
Other sites Male 4.5 19.7 48.1 93.2 146.0 16.1 4.6 23.1 45.5 105.6 169.7 17.3 4.6 25.5 44.6 113.6 189.7 18.4
Other sites Female 3.9 18.2 39.4 68.8 95.5 12.6 4.1 20.8 38.1 78.9 105.5 13.6 4.4 22.5 37.4 88.2 118.9 14.6
Table 3 Changes in the numbers of deaths between 2000 (2005) and 1991 and relative changes due to changed risk, population age structure and
population size, by cancer site and sex
Year 1991 Year 2000 Year 2005
Change compared
with 1991 Change (%) due to
Change compared
with 1991 Change (%) due to
Cancer Sex No. of deaths
No. of
deaths No. % Risk Pop
No. of
deaths No. % Risk Pop
All sites Male 751 921 992 585 240 664 32.0 1.1 33.1 1 111 143 359 223 47.8 0.3 48.1
All sites Female 421 282 549 962 128 680 30.5 0.2 30.3 648 930 227 648 54.0 4.6 49.4
Stomach Male 181 481 200 518 19 037 10.5 24.7 35.2 197 222 15 741 8.7 42.1 50.8
Stomach Female 88 790 95942 7152 8.1 23.9 31.9 97 843 9054 10.2 41.9 52.1
Oesophagus Male 121 508 131 794 10 285 8.5 27.4 35.9 127 726 6218 5.1 46.5 51.7
Oesophagus Female 63 756 60 598 3159 5.0 37.3 32.4 57 485 6272 9.8 62.9 53.1
Liver Male 162 004 225 486 63 483 39.2 8.3 30.9 256 679 94 675 58.4 13.1 45.3
Liver Female 58 620 84 349 25 729 43.9 13.2 30.7 100 945 42 325 72.2 22.8 49.4
Lung Male 134 748 224 807 90 058 66.8 32.5 34.4 285 785 151 037 112.1 62.1 50.0
Lung Female 56 468 102 836 46 368 82.1 50.5 31.6 143 151 86 683 153.5 102.0 51.6
Colorectal Male 32 290 48 869 16 579 51.3 16.6 34.7 58 553 26 263 81.3 31.6 49.8
Colorectal Female 25 669 33 913 8244 32.1 0.5 31.6 40 429 14 761 57.5 6.0 51.5
Cervix Female 20 197 21 461 1264 6.3 25.9 32.2 22 975 2778 13.8 37.7 51.4
Breast (female) Female 18 857 34 927 16 070 85.2 54.8 30.4 48 164 29 307 155.4 107.5 47.9
Leukaemia Male 22 861 26 585 3724 16.3 3.2 13.1 29 640 6779 29.7 8.1 21.6
Leukaemia Female 17 996 18 322 327 1.8 10.7 12.5 19 094 1098 6.1 16.6 22.7
Nasopharynx Male 13 207 15 670 2463 18.7 11.5 30.2 16 400 3193 24.2 20.3 44.5
Nasopharynx Female 5819 7095 1276 21.9 7.4 29.3 7802 1983 34.1 12.8 46.9
Bladder Male 8203 11 417 3214 39.2 1.5 40.7 12 935 4732 57.7 0.6 57.1
Bladder Female 2845 3675 830 29.2 4.5 33.7 4430 1585 55.7 0.4 55.3
Other sites Male 75 619 107 439 31 821 42.1 10.9 31.2 126 204 50 585 66.9 21.5 45.4
Other sites Female 62 264 86 844 24 579 39.5 11.0 28.5 106 611 44 347 71.2 24.5 46.7
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DISCUSSION
Comparison of the two national mortality surveys (in 1973–1975
and 1990–1992) suggests that the second, although based on only a
10% sample of the population, was highly representative of the
country as a whole (Li et al, 1996; Li et al, 1997; Yang et al, 2003a).
It thus provides a valid baseline (for 1991) from which to project
the future cancer mortality. The time trends used to project
forward these rates to 2000 and 2005 derive from the CHIS routine
sample survey of mortality system. In using these trends, the
assumption is that they are representative of the national trends in
urban and rural areas. During the study period, there were few
notable changes in the population and sampling sites covered by
the CHIS system. However, the geographic areas covered by the
CHIS system are mainly on the eastern seaboard, the most densely
populated areas of China (NOCPC, 2001), being urbanised than the
national population (Rao et al, 1989; NCHIS, 1999). By combining
estimates and predictions of age-specific and ASRs by rural and
urban area, we obtained the estimates of national mortality in 2000
and 2005. The nonrepresentative nature of the CHIS sample is the
probable explanation for the differences between its 1991 rates and
those in the second national survey, the former being lower
for certain cancers such as oesophagus and stomach and higher,
in urban areas, for female breast, colon-rectum and lung.
Nevertheless, it is not the values of the mortality rates in CHIS
that have been used to make a national prediction, but the trends
Figure 2 Total number of deaths for certain cancers in the years 1990, 2000 and 2005 in China, by site and sex.
Table 4 Observed and estimated number of deaths, age-standard mortality rates with 95% estimated intervals produced by different models for four
cancers in CHIS data for the year 1999
Number of deaths Age-standard mortality (per 100 000)
Cancer Model Observed Estimated 95% confidence interval Observed Estimated 95% confidence interval
Lung (1) 3460 3218.8 3067.7 3369.8 12.6 11.7 11.2 12.3
(2) 3460 3217.6 3066.7 3368.5 12.6 11.8 11.2 12.3
(3) 3460 3161.7 2906.1 3417.4 12.6 11.5 10.6 12.5
(4) 3460 2605.3 2473.4 2777.2 12.6 9.6 9.0 10.1
Breast (1) 1268 1127.6 1033.6 1221.6 4.8 4.3 3.9 4.7
(2) 1268 1121.9 1013.5 1230.4 4.8 4.2 3.8 4.7
(3) 1268 1104.6 957.4 1251.8 4.8 4.2 3.7 4.8
(4) 1268 946.3 867.1 1025.4 4.8 3.6 3.3 3.9
Oesophagus (1) 1690 1442.1 1328.1 1556.1 4.1 3.7 3.4 4.0
(2) 1690 1434.9 1313.7 1556.0 4.1 3.7 3.4 4.0
(3) 1690 1420.2 1051.6 1788.9 4.1 3.6 2.7 4.6
(4) 1690 1413.6 1276.5 1550.8 4.1 3.6 3.3 4.0
Cervix (1) 703 657.0 595.2 718.8 1.9 1.8 1.6 1.9
(2) 703 642.4 550.5 734.3 1.9 1.7 1.4 1.9
(3) 703 614.9 510.6 719.2 1.9 1.7 1.4 1.9
(4) 703 619.9 514.0 725.7 1.9 1.6 1.3 1.9
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within strata of age, sex and urban– rural residence. These trends
have been examined in detail elsewhere (Yang et al, 2003b), where
it was noted that although there had been no changes in the areas
covered by the sample during 1991–1999, there had been
important social and demographic shifts within them, with rapid
economic development and marked urban– rural migration. These
will have influenced the trends observed within the urban–rural
samples in addition to changes in exposures to risk factors, early
detection and treatment.
Predictions of future cancer patterns use a variety of modelling
strategies (Teppo et al, 1974; Osmond, 1985; Clayton and
Schifflers, 1987; Hakulinen and Dyba, 1994; Hakulinen, 1996;
Dyba and Hakulinen, 2000), their reliability depending directly on
the choice of model and the explanatory variables fitted. In the
absence of information on the trends in exposure to relevant risk
factors, the most practical and plausible method is to use simple
time-linear models on the arithmetic or logarithmic scale (Dyba
and Hakulinen, 2000). Since the actual projection period in our
study is short (6 years, 1999– 2005), we used only the log-linear
model (1), rather than models more appropriate for increasing
rates that specify an identity link function (Hakulinen and Dyba,
1994; Dyba and Hakulinen, 2000). Since the Poisson assumption
for the number of cases has been shown to be superior to methods
that assume a normal distribution for the rates (Dyba and
Hakulinen, 2000), our model specified Poisson errors for the
age- and period-specific numbers of deaths, under the assumption
that the observed rates of change within age groups would
continue into the near future in a log-linear manner. This method
closely replicated the changes observed in the CHIS mortality data
set during 1991–1999 and, in the population used for the national
survey in 1990–1992. However, future projections using this
method may give rise to implausible distortions in the pattern of
age-specific mortality for specific cancers, if the rate of change
differs markedly by age group; continuation of exponential
increases, in particular, can lead to ‘explosive’ forecasts if the
projection period is long (Teppo et al, 1974). In fact, with this
short projection period, the final age-specific patterns of mortality
mainly appear reasonable (Table 2). Even so, some strange
patterns emerge. In breast cancer, for example, age-specific
mortality increases little between ages 45 –54 and 75þ years,
while for cervix cancer, the mortality in 2005 is highest in the age
group 45– 54 years (11.3 per 105), decreases at ages 55– 64 years (to
7.5 per 105) and then rises again (to 10.9 per 105 at ages 75þ ).
These are the consequences of large rates of change in the CHIS
data between 1991 and 1999 that differ by age; for breast cancer in
urban female subjects, and for cervix cancer, the large increases in
younger women presumably represent birth-cohort-specific
changes in risk (Yang et al, 2003b).
Projections of cancer incidence or mortality rates based on past
trends will not necessarily be accurate since they can be modified
by factors that affect the risk of cancer, or its outcome; rather,
projections illustrate what would have happened, if past experience
continued. This in itself can be useful, as a way of establishing a
baseline, or target, against which the success or failure of cancer
control interventions can be evaluated (Hakulinen, 1996). Extra-
polation of past trends beyond a decade or two is likely to be
meaningless, and for China, in particular, the huge changes in
socioeconomic situation, diet, lifestyle and environmental factors
mean that all but the most short-term predictions are likely to be
unrealistic. Even with our short projected period, we observe some
changes that are unexpected and difficult to explain, for example,
the implausible declining trend of colon-rectum cancer in rural
female subjects, and the much more rapidly increasing trend of
breast cancer in rural than in urban female subjects.
Declining ASRs are seen for oesophagus, stomach, cervix and
nasopharynx cancers (Table 2 and Appendix A). However,
demographic changes mean that the actual numbers of deaths
from these cancers will increase (the population component of
change exceeds the decline due to risk), except for oesophagus
cancer in female subjects (Table 3). The declining ASRs are,
however, largely due to declining mortality rates at age 55 years
and above. At younger ages, the trend is positive for certain sites
(Table 1): notably cervix cancer, especially in urban populations
though decreasing in older women. Compared with the 1991 rates,
those for women under 55 years were 68.5% higher in 2000, 105.0%
higher in 2005, while for women over 55 years, 40.2% lower in 2000
and 56.0% lower in 2005. These age-specific trends mean that
simple projection of mortality rates within age groups is likely to
be misleading, and the rate of decline will certainly slow, or even
reverse. The effect on the very short-term projection (6 years) in
this paper is, however, likely to be small.
The remarkable changes in mortality for most major cancers,
and their possible explanations have been the subject of an earlier
communication (Yang et al, 2003b). The very large improvements
in socioeconomic and sanitary conditions may be responsible for
declines in cancers associated with infection and/or nutritional
deficiency, such as oesophagus, stomach, cervix uteri and
nasopharynx, while changes in diet and a more sedentary lifestyle,
associated with an increasing prevalence of obesity, may explain
some of the changes in risk for cancers of the breast and large
bowel. Cigarette smoking is a risk factor for several cancers,
including the lung, bladder, oesophagus, stomach, liver and cervix
(IARC, 2002), and the epidemic of cigarette smoking in China is a
major determinant of past and future cancer trends (Gao et al,
1994; Ji et al, 1997; CTSU, 1998; Liu et al, 1998).
Mortality patterns are also influenced by changes in cancer
survival, which may be a consequence of earlier diagnosis, therapy
or both. Some of the declines in cervix cancer mortality, most
marked in urban areas, may be attributed to screening pro-
grammes. Survival from breast cancer in Tianjin increased
between 1981 and 1987, and mortality rates declined, changes
that were attributed to early detection programmes (Hao et al,
2002).
Despite the dramatic trends in mortality rates observed in the
last decade, population growth and ageing are responsible for the
largest component of change in the number of deaths for most
cancers in 1991– 2005. For most cancer sites (and for all cancers
combined), the increase in the number of deaths from this
component was around 50%. In the last 50 years, the Chinese
population has increased dramatically, from 550 million in 1950 to
1.24 billion in 2000, and is projected to be 1.43 billion in 2020 (UN
Population Division, 2003). With a declining birth rate (total
fertility rate had fallen to just 1.8 children per women by 2000) and
increasing expectation of life at birth, ageing will be an important
characteristic of the Chinese population in the 21st century. Future
population projections are based on the assumptions concerning
the continuation or maintenance of such trends. Differences in the
fertility or mortality assumptions could cause discrepancies in
projected total population of up to 200 million or more within a
25-year projection period (UN Population Division, 2002b),
although the numbers of persons in the age groups at significant
risk of cancer (say 35 and above) can be fairly confidently
predicted for the next 25 years. The population for 2005 used in
this study was an estimate of the UN Population division (2003).
Comparing this with the 2000 census shows some large
discrepancies among children, e.g. 27 million more children aged
5–9 years in 2005 than children aged 0 –4 years in 2000 (Figure 1),
presumably due to erroneous projections of fertility. However,
since most cancers occur at older ages, these errors will have very
little effect on our results.
It is clear from Figure 2 that cancer will make an increasing
contribution to the burden of disease in China in the 21st century.
The marked increases in lung, female breast and colon-rectum
cancers and the possibly underestimated increases in cervix cancer
in younger women, along with the huge burden from common
cancers such as oesophagus, stomach and liver, indicate the
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priorities for future cancer prevention and control programmes.
Our projections should provide a useful benchmark against which
to judge the success of cancer control work in China in the near
future.
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The observed, estimated and predicted age-standardised mortality
rates for certain cancers in China, from 1991– 2005, by site, sex and
area (Figure 3).
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Figure 3 (continued).
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